Daxor launches Kansas BVA program
Analysis based on 6 articles · First reported Jul 30, 2026 · Last updated Jul 30, 2026
The launch is a modest positive for Daxor, potentially increasing adoption of its BVA technology and revenue. However, the impact on broader markets is negligible given the company's small size.
Daxor Corporation announced the launch of a new outpatient Blood Volume Analysis (BVA) program at a leading healthcare facility in eastern Kansas, expanding its presence in Midwestern outpatient care. The program uses Daxor's turnkey ezBVA Lab send-out model, enabling 98% accurate blood volume measurements within 24 hours without capital equipment. This initiative aims to improve patient outcomes and reduce readmissions through precise fluid management.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard